Archives

by in
Entry Author Date Location
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News 12/09/09 Boston
Supercharged Herceptin Nears Pivot Point, as ImmunoGen, Roche Await Data on Breast Cancer “Smart Bomb” 12/07/09 Boston
Ironwood Pharma Eyes $172.5M IPO, Biogen CEO Pay Under Fire, & More Boston Life Sciences News 11/25/09 Boston
Metcalfe Reflects on $2.7B 3Com Buyout, MyPunchbowl Parent Adds New Punch, $30M More for Fate Therapeutics, & More Boston Deals News 11/20/09 Boston
ImmunoGen Nabs $1M From Amgen 11/19/09 Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten 10/08/09 Boston
Ambrx Strikes Deal With Wyeth (Soon-to-be Pfizer) to Make Antibody Drugs 09/18/09 San Diego
Life Science Leaders Converge in Newport, PubGet Gets Your Paper Faster, I-Therapeutix Eyes $15M Prize & More Boston-Area Life Sciences News 06/24/09 Boston
Data Domain Fight Continues, Adimab Adds Merck and Roche as Partners, BigBelly Solar Gets Dirty With Waste Management, & More Boston-Area Deals News 06/22/09 Boston
ImmunoGen Grabs $33M in Stock Sale 06/18/09 Boston
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News 06/03/09 Boston
ASCO Weekend Highlights: ImmunoGen, Antigenics, Aveo Show Off Cancer Drug Findings 06/01/09 Boston
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News 05/20/09 Boston
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data 05/15/09 Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter 03/17/09 Boston
ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News 03/11/09 Boston
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News 03/06/09 Boston
Souped-Up Herceptin Aims to Validate ImmunoGen’s Long-Sought Dream Cancer Drug 03/06/09 Boston
Synta Melanoma Drug Trial Halted, Drug Regulators Hand Genzyme Mixed Bag, Ariad and ImmunoGen Reach Milestones, & More Boston-Area Life Sciences News 03/04/09 Boston
ImmunoGen Gets $6.5M Milestone Fee 03/03/09 Boston
Biogen Confirms HQ Move from Cambridge to Suburbs 12/02/08 Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
Akamai Acquires Acerno, Archemix Adds Eli Lilly to Partner List, Sermo Signs Up Bloomberg Subscribers, & More Boston-Area Deals News 10/27/08 Boston
Bayer Buys License to ImmunoGen Cancer Drug Technology 10/21/08 Boston
Janius to Replace Sayer as CEO of ImmunoGen 09/30/08 Boston
$37 Million for Nanotech Insulation, $25 Million for ImmunoGen, $325 Million for Evergreen Solar, & More Deals News 06/30/08 Boston
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News 06/25/08 Boston
Immunogen Sells Stock, Raises $25M 06/23/08 Boston
ImmunoGen Scores $1.5M From Biogen Idec 02/04/08 Boston
ImmunoGen’s Mitch Sayare on What Sustains a Company—and its CEO—Through Decades of Starting Up 01/29/08 Boston
Page 2 of 2 « previous page
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.